Global Hereditary Angioedema Treatment Professional Survey Report 2022, Forecast to 2027

Code: RW00014702223
Multimarket Insight
Jul-2022
Life Sciences
102 Pages

Medicines called danazol and oxandrolone can help reduce the chances of swelling occurring if you have hereditary angioedema. These medicines boost the levels of C1 esterase inhibitor in your blood. Low levels of this substance are what causes the swelling.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Hereditary Angioedema Treatment industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)

Market Segment by Product Application
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)

Finally, the report provides detailed profile and data information analysis of leading company.
CSL
Ionis Pharmaceuticals
Pharming Group
KalVista Pharmaceuticals
Shire plc (Takeda Pharmaceutical Company Limited)
BioCryst Pharmaceuticals
Attune Pharmaceuticals

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Hereditary Angioedema Treatment consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Hereditary Angioedema Treatment market by identifying its various subsegments.
3.Focuses on the key global Hereditary Angioedema Treatment manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Hereditary Angioedema Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Hereditary Angioedema Treatment submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Hereditary Angioedema Treatment Professional Survey Report Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 Hereditary Angioedema Treatment Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Hereditary Angioedema Treatment Segment by Type
2.1.1 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
2.1.2 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
2.1.3 Kallikrein Inhibitors (Kalbitor, Takhzyro)
2.1.4 Others (Conventional Drugs, Pipeline Drugs)
2.2 Market Analysis by Application
2.2.1 Hospital Pharmacies
2.2.2 Retail Pharmacies
2.2.3 Others (online pharmacies, mail pharmacies)
2.3 Global Hereditary Angioedema Treatment Market Comparison by Regions (2017-2027)
2.3.1 Global Hereditary Angioedema Treatment Market Size (2017-2027)
2.3.2 North America Hereditary Angioedema Treatment Status and Prospect (2017-2027)
2.3.3 Europe Hereditary Angioedema Treatment Status and Prospect (2017-2027)
2.3.4 Asia-pacific Hereditary Angioedema Treatment Status and Prospect (2017-2027)
2.3.5 South America Hereditary Angioedema Treatment Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Hereditary Angioedema Treatment Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Hereditary Angioedema Treatment Industry Impact
2.5.1 Hereditary Angioedema Treatment Business Impact Assessment - Covid-19
2.5.2 Market Trends and Hereditary Angioedema Treatment Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Hereditary Angioedema Treatment Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Hereditary Angioedema Treatment Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Hereditary Angioedema Treatment Manufacturer Market Share
3.5 Top 10 Hereditary Angioedema Treatment Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Hereditary Angioedema Treatment Market
3.7 Key Manufacturers Hereditary Angioedema Treatment Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Hereditary Angioedema Treatment Industry Key Manufacturers
4.1 CSL
4.1.1 Company Details
4.1.2 CSL Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.1.3 CSL Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 CSL News
4.2 Ionis Pharmaceuticals
4.2.1 Company Details
4.2.2 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.2.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Ionis Pharmaceuticals News
4.3 Pharming Group
4.3.1 Company Details
4.3.2 Pharming Group Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.3.3 Pharming Group Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Pharming Group News
4.4 KalVista Pharmaceuticals
4.4.1 Company Details
4.4.2 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.4.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 KalVista Pharmaceuticals News
4.5 Shire plc (Takeda Pharmaceutical Company Limited)
4.5.1 Company Details
4.5.2 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.5.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Shire plc (Takeda Pharmaceutical Company Limited) News
4.6 BioCryst Pharmaceuticals
4.6.1 Company Details
4.6.2 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 BioCryst Pharmaceuticals News
4.7 Attune Pharmaceuticals
4.7.1 Company Details
4.7.2 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.7.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Attune Pharmaceuticals News

5 Global Hereditary Angioedema Treatment Sales Categorized by Regions
5.1 Global Hereditary Angioedema Treatment Revenue, Sales and Market Share by Regions
5.1.1 Global Hereditary Angioedema Treatment Sales and Market Share by Regions (2017-2022)
5.1.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Regions (2017-2022)
5.2 North America Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
5.3 Europe Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
5.5 South America Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)

6 North America Hereditary Angioedema Treatment Market Size Categorized by Countries
6.1 North America Hereditary Angioedema Treatment Sales, Revenue and Market Share by Countries
6.1.1 North America Hereditary Angioedema Treatment Sales (Volume) by Countries (2017-2022)
6.1.2 North America Hereditary Angioedema Treatment Revenue by Countries (2017-2022)
6.1.3 United States Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
6.1.4 Canada Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
6.1.5 Mexico Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
6.2 North America Hereditary Angioedema Treatment Revenue (Value) by Manufacturers
6.3 North America Hereditary Angioedema Treatment Sales and Market Share by Type (2017-2022)
6.4 North America Hereditary Angioedema Treatment Sales Market Share by Application (2017-2022)

7 Europe Hereditary Angioedema Treatment Market Size Categorized by Countries
7.1 Europe Hereditary Angioedema Treatment Sales, Revenue and Market Share by Countries
7.1.1 Europe Hereditary Angioedema Treatment Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Hereditary Angioedema Treatment Revenue by Countries (2017-2022)
7.1.3 Germany Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
7.1.4 UK Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
7.1.5 France Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
7.1.6 Russia Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
7.1.7 Italy Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
7.1.8 Spain Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
7.2 Europe Hereditary Angioedema Treatment Revenue (Value) by Manufacturers
7.3 Europe Hereditary Angioedema Treatment Sales and Market Share by Type (2017-2022)
7.4 Europe Hereditary Angioedema Treatment Sales Market Share by Application (2017-2022)

8 Asia-Pacific Hereditary Angioedema Treatment Market Size Categorized by Countries
8.1 Asia-pacific Hereditary Angioedema Treatment Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Hereditary Angioedema Treatment Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Hereditary Angioedema Treatment Revenue by Countries (2017-2022)
8.1.3 China Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
8.1.4 South Korea Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
8.1.5 Japan Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
8.1.6 Australia Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
8.1.7 India Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Hereditary Angioedema Treatment Revenue (Value) by Manufacturers
8.3 Asia-pacific Hereditary Angioedema Treatment Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Hereditary Angioedema Treatment Sales Market Share by Application (2017-2022)

9 South America Hereditary Angioedema Treatment Market Size Categorized by Countries
9.1 South America Hereditary Angioedema Treatment Sales, Revenue and Market Share by Countries
9.1.1 South America Hereditary Angioedema Treatment Sales (Volume) by Countries (2017-2022)
9.1.2 South America Hereditary Angioedema Treatment Revenue by Countries (2017-2022)
9.1.3 Brazil Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
9.2 South America Hereditary Angioedema Treatment Sales and Market Share by Type (2017-2022)
9.3 South America Hereditary Angioedema Treatment Sales Market Share by Application (2017-2022)

10 Middle East and Africa Hereditary Angioedema Treatment Market Size Categorized by Countries
10.1 Middle East and Africa Hereditary Angioedema Treatment Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Hereditary Angioedema Treatment Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Hereditary Angioedema Treatment Revenue by Countries (2017-2022)
10.1.3 GCC Countries Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
10.1.4 Turkey Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
10.1.5 Egypt Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
10.1.6 South America Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Hereditary Angioedema Treatment Sales and Market Share by Type
10.3 Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Application (2017-2022)

11 Global Hereditary Angioedema Treatment Market Segment by Type
11.1 Global Hereditary Angioedema Treatment Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Hereditary Angioedema Treatment Sales and Market Share by Type (2017-2022)
11.1.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Type (2017-2022)
11.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Sales Growth Rate and Price
11.2.1 Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Sales Growth Rate (2017-2022)
11.2.2 Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Price (2017-2022)
11.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr) Sales Growth Rate and Price
11.3.1 Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Sales Growth Rate (2017-2022)
11.3.2 Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Price (2017-2022)
11.4 Kallikrein Inhibitors (Kalbitor, Takhzyro) Sales Growth Rate and Price
11.4.1 Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Sales Growth Rate (2017-2022)
11.4.2 Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Price (2017-2022)
11.5.1 Global Others (Conventional Drugs, Pipeline Drugs) Sales Growth Rate (2017-2022)
11.5.2 Global Others (Conventional Drugs, Pipeline Drugs) Price (2017-2022)

12 Global Hereditary Angioedema Treatment Market Segment by Application
12.1 Global Hereditary Angioedema Treatment Sales Market Share by Application (2017-2022)
12.2 Hospital Pharmacies Sales Growth Rate (2017-2022)
12.3 Retail Pharmacies Sales Growth Rate (2017-2022)
12.4 Others (online pharmacies, mail pharmacies) Sales Growth Rate (2017-2022)

13 Global Hereditary Angioedema Treatment Market Forecast
13.1 Global Hereditary Angioedema Treatment Revenue, Sales and Growth Rate (2022-2027)
13.2 Hereditary Angioedema Treatment Market Forecast by Regions (2022-2027)
13.2.1 North America Hereditary Angioedema Treatment Market Forecast (2022-2027)
13.2.2 Europe Hereditary Angioedema Treatment Market Forecast (2022-2027)
13.2.3 Asia-Pacific Hereditary Angioedema Treatment Market Forecast (2022-2027)
13.2.4 South America Hereditary Angioedema Treatment Market Forecast (2022-2027)
13.2.5 Middle East & Africa Hereditary Angioedema Treatment Market Forecast (2022-2027)
13.3 Hereditary Angioedema Treatment Market Forecast by Type (2022-2027)
13.3.1 Global Hereditary Angioedema Treatment Sales Forecast by Type (2022-2027)
13.3.2 Global Hereditary Angioedema Treatment Market Share Forecast by Type (2022-2027)
13.4 Hereditary Angioedema Treatment Market Forecast by Application (2022-2027)
13.4.1 Global Hereditary Angioedema Treatment Sales Forecast by Application (2022-2027)
13.4.2 Global Hereditary Angioedema Treatment Market Share Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Hereditary Angioedema Treatment Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Hereditary Angioedema Treatment Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture Hereditary Angioedema Treatment
Figure Market Concentration Ratio and Market Maturity Analysis of Hereditary Angioedema Treatment
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Hereditary Angioedema Treatment Market Size by Type
Figure Global Market Share of Hereditary Angioedema Treatment by Type in 2021
Figure C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Picture
Figure Selective Bradykinin B2 Receptor Antagonists (Firazyr) Picture
Figure Kallikrein Inhibitors (Kalbitor, Takhzyro) Picture
Figure Others (Conventional Drugs, Pipeline Drugs) Picture
Table Global Hereditary Angioedema Treatment Market Size (Volume) by Application
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Others (online pharmacies, mail pharmacies) Picture
Table Global Hereditary Angioedema Treatment Comparison by Regions (M USD) 2017-2027
Figure Global Hereditary Angioedema Treatment Market Size (Million US$) (2017-2027)
Figure North America Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Hereditary Angioedema Treatment Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Hereditary Angioedema Treatment Sales by Manufacturer (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Manufacturer in 2021
Table Global Hereditary Angioedema Treatment Revenue by Manufacturer (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue Market Share by Manufacturer in 2021
Table Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Hereditary Angioedema Treatment Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Hereditary Angioedema Treatment Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Hereditary Angioedema Treatment Market
Table Key Manufacturers Hereditary Angioedema Treatment Product Type
Table Mergers & Acquisitions Planning
Table CSL Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of CSL
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of CSL 2017-2022
Table CSL Main Business
Table CSL Recent Development
Table Ionis Pharmaceuticals Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of Ionis Pharmaceuticals
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ionis Pharmaceuticals 2017-2022
Table Ionis Pharmaceuticals Main Business
Table Ionis Pharmaceuticals Recent Development
Table Pharming Group Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of Pharming Group
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pharming Group 2017-2022
Table Pharming Group Main Business
Table Pharming Group Recent Development
Table KalVista Pharmaceuticals Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of KalVista Pharmaceuticals
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of KalVista Pharmaceuticals 2017-2022
Table KalVista Pharmaceuticals Main Business
Table KalVista Pharmaceuticals Recent Development
Table Shire plc (Takeda Pharmaceutical Company Limited) Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of Shire plc (Takeda Pharmaceutical Company Limited)
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Shire plc (Takeda Pharmaceutical Company Limited) 2017-2022
Table Shire plc (Takeda Pharmaceutical Company Limited) Main Business
Table Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
Table BioCryst Pharmaceuticals Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of BioCryst Pharmaceuticals
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of BioCryst Pharmaceuticals 2017-2022
Table BioCryst Pharmaceuticals Main Business
Table BioCryst Pharmaceuticals Recent Development
Table Attune Pharmaceuticals Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of Attune Pharmaceuticals
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Attune Pharmaceuticals 2017-2022
Table Attune Pharmaceuticals Main Business
Table Attune Pharmaceuticals Recent Development
Figure Global Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue and Growth Rate (2017-2022)
Table Global Hereditary Angioedema Treatment Sales by Regions (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Regions in 2021
Table Global Hereditary Angioedema Treatment Revenue by Regions (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue Market Share by Regions in 2021
Figure North America Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Europe Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Asia-pacific Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure South America Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure North America Hereditary Angioedema Treatment Revenue and Growth Rate (2017-2022)
Table North America Hereditary Angioedema Treatment Sales (Volume) by Countries (2017-2022)
Table North America Hereditary Angioedema Treatment Sales Market Share by Countries (2017-2022)
Figure North America Hereditary Angioedema Treatment Sales Market Share by Countries in 2021
Table North America Hereditary Angioedema Treatment Revenue by Countries (2017-2022)
Table North America Hereditary Angioedema Treatment Revenue Market Share by Countries (2017-2022)
Figure North America Hereditary Angioedema Treatment Revenue Market Share by Countries in 2021
Figure United States Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Canada Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Mexico Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Table North America Hereditary Angioedema Treatment Revenue by Manufacturer (2021)
Figure North America Hereditary Angioedema Treatment Revenue Market Share by Manufacturer in 2021
Table North America Hereditary Angioedema Treatment Sales by Type (2017-2022)
Table North America Hereditary Angioedema Treatment Sales Share by Type (2017-2022)
Table North America Hereditary Angioedema Treatment Sales by Application (2017-2022)
Table North America Hereditary Angioedema Treatment Sales Share by Application (2017-2022)
Figure Europe Hereditary Angioedema Treatment Revenue and Growth Rate (2017-2022)
Table Europe Hereditary Angioedema Treatment Sales (Volume) by Countries (2017-2022)
Table Europe Hereditary Angioedema Treatment Sales Market Share by Countries (2017-2022)
Figure Europe Hereditary Angioedema Treatment Sales Market Share by Countries in 2021
Table Europe Hereditary Angioedema Treatment Revenue by Countries (2017-2022)
Table Europe Hereditary Angioedema Treatment Revenue Market Share by Countries (2017-2022)
Figure Europe Hereditary Angioedema Treatment Revenue Market Share by Countries in 2021
Figure Germany Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure UK Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure France Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Russia Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Italy Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Spain Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Table Europe Hereditary Angioedema Treatment Revenue by Manufacturer (2021)
Figure Europe Hereditary Angioedema Treatment Revenue Market Share by Manufacturer in 2021
Table Europe Hereditary Angioedema Treatment Sales by Type (2017-2022)
Table Europe Hereditary Angioedema Treatment Sales Share by Type (2017-2022)
Table Europe Hereditary Angioedema Treatment Sales by Application (2017-2022)
Table Europe Hereditary Angioedema Treatment Sales Share by Application (2017-2022)
Figure Asia-pacific Hereditary Angioedema Treatment Revenue and Growth Rate (2017-2022)
Table Asia-pacific Hereditary Angioedema Treatment Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Hereditary Angioedema Treatment Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Hereditary Angioedema Treatment Sales Market Share by Countries in 2021
Table Asia-pacific Hereditary Angioedema Treatment Revenue by Countries (2017-2022)
Table Asia-pacific Hereditary Angioedema Treatment Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Hereditary Angioedema Treatment Revenue Market Share by Countries in 2021
Figure China Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure South Korea Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Japan Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Australia Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure India Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Southeast Asia Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Table Asia-pacific Hereditary Angioedema Treatment Revenue by Manufacturer (2021)
Figure Asia-pacific Hereditary Angioedema Treatment Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Hereditary Angioedema Treatment Sales by Type (2017-2022)
Table Asia-pacific Hereditary Angioedema Treatment Sales Share by Type (2017-2022)
Table Asia-pacific Hereditary Angioedema Treatment Sales by Application (2017-2022)
Table Asia-pacific Hereditary Angioedema Treatment Sales Share by Application (2017-2022)
Figure South America Hereditary Angioedema Treatment Revenue and Growth Rate (2017-2022)
Table South America Hereditary Angioedema Treatment Sales (Volume) by Countries (2017-2022)
Table South America Hereditary Angioedema Treatment Sales Market Share by Countries (2017-2022)
Figure South America Hereditary Angioedema Treatment Sales Market Share by Countries in 2019
Table South America Hereditary Angioedema Treatment Revenue by Countries (2017-2022)
Table South America Hereditary Angioedema Treatment Revenue Market Share by Countries (2017-2022)
Figure South America Hereditary Angioedema Treatment Revenue Market Share by Countries in 2019
Figure Brazil Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Table South America Hereditary Angioedema Treatment Sales by Type (2017-2022)
Table South America Hereditary Angioedema Treatment Sales Share by Type (2017-2022)
Table South America Hereditary Angioedema Treatment Revenue by Type (2017-2022)
Table South America Hereditary Angioedema Treatment Revenue Share by Type (2017-2022)
Table South America Hereditary Angioedema Treatment Sales by Application (2017-2022)
Table South America Hereditary Angioedema Treatment Sales Share by Application (2017-2022)
Figure Middle East and Africa Hereditary Angioedema Treatment Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Hereditary Angioedema Treatment Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Countries in 2019
Table Middle East and Africa Hereditary Angioedema Treatment Revenue by Countries (2017-2022)
Table Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Countries in 2019
Figure GCC Countries Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Turkey Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Egypt Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure South Africa Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Table Middle East and Africa Hereditary Angioedema Treatment Sales by Type (2017-2022)
Table Middle East and Africa Hereditary Angioedema Treatment Sales Share by Type (2017-2022)
Table Middle East and Africa Hereditary Angioedema Treatment Revenue by Type (2017-2022)
Table Middle East and Africa Hereditary Angioedema Treatment Revenue Share by Type (2017-2022)
Table Middle East and Africa Hereditary Angioedema Treatment Sales by Application (2017-2022)
Table Middle East and Africa Hereditary Angioedema Treatment Sales Share by Application (2017-2022)
Table Global Hereditary Angioedema Treatment Sales by Type (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Market Share by Type (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Type in 2021
Table Global Hereditary Angioedema Treatment Revenue by Type (2017-2022)
Table Global Hereditary Angioedema Treatment Revenue Market Share by Type (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue Market Share by Type in 2019
Figure Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Sales Growth Rate (2017-2022)
Figure Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Price (2017-2022)
Figure Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Sales Growth Rate (2017-2022)
Figure Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Price (2017-2022)
Figure Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Sales Growth Rate (2017-2022)
Figure Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Price (2017-2022)
Figure Global Others (Conventional Drugs, Pipeline Drugs) Sales Growth Rate (2017-2022)
Figure Global Others (Conventional Drugs, Pipeline Drugs) Price (2017-2022)
Table Global Hereditary Angioedema Treatment Sales by Application (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Market Share by Application (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Application in 2021
Figure Global Hospital Pharmacies Sales Growth Rate (2017-2022)
Figure Global Retail Pharmacies Sales Growth Rate (2017-2022)
Figure Global Others (online pharmacies, mail pharmacies) Sales Growth Rate (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales and Growth Rate (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue and Growth Rate (2022-2027)
Table Global Hereditary Angioedema Treatment Sales Forecast by Regions (2017-2022)
Table Global Hereditary Angioedema Treatment Market Share Forecast by Regions (2017-2022)
Figure North America Sales Hereditary Angioedema Treatment Market Forecast (2022-2027)
Figure Europe Sales Hereditary Angioedema Treatment Market Forecast (2022-2027)
Figure Asia-Pacific Sales Hereditary Angioedema Treatment Market Forecast (2022-2027)
Figure South America Sales Hereditary Angioedema Treatment Market Forecast (2022-2027)
Figure Middle East & Africa Sales Hereditary Angioedema Treatment Market Forecast (2022-2027)
Table Global Hereditary Angioedema Treatment Sales Forecast by Type (2022-2027)
Table Global Hereditary Angioedema Treatment Market Share Forecast by Type (2022-2027)
Table Global Hereditary Angioedema Treatment Sales Forecast by Application (2022-2027)
Table Global Hereditary Angioedema Treatment Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hereditary Angioedema Treatment
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List

CSL
Ionis Pharmaceuticals
Pharming Group
KalVista Pharmaceuticals
Shire plc (Takeda Pharmaceutical Company Limited)
BioCryst Pharmaceuticals
Attune Pharmaceuticals

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE